Table 5.
Summary of core indicators of HBV and HCV in South Korea
Variables | 2018 | 2019 | 2020 | Average (2018-2020) | WHO Targets* (2030) | |
---|---|---|---|---|---|---|
HBV | Annual incidence rate (per 100,000 persons) | 0.73 | 0.73 | 0.69 | 0.71 | - |
Linkage-to-care rate | 37.6 | 44.4 | 36.2 | 39.4% | ≥90% | |
Treatment rate | 64.2 | 73.2 | 64.5 | 67.3% | ≥80% | |
Liver-related annual mortality rate (per 100,000 persons) | 19.72 | 18.90 | 17.94 | 18.85 | ≤4 | |
HCV | Annual incidence rate (per 100,000 persons) | 12.7 | 12.0 | 11.0 | 11.9 | ≤5 |
Linkage-to-care rate | 74.2 | 69.9 | 52.3 | 65.5% | ≥90% | |
Treatment rate | 56.9 | 60.5 | 53.0 | 56.8% | ≥80% | |
Liver-related annual mortality rate (per 100,000 persons) | 2.26 | 1.99 | 1.81 | 2.02 | ≤2 |
HBV, hepatitis B virus; HCV hepatitis C virus; CHB, chronic hepatitis B; CHC, chronic hepatitis C.
Impact and programmatic targets for country validation of elimination for HBV and HCV incidence and mortality.